-Patrice Viens Researcher Activity Profile

Research Author Detailed Information 

Patrice Viens Publication Rate By Year

Patrice Viens has published 1 paper(s) in 1974, 1 paper(s) in 1975, 1 paper(s) in 1977, 2 paper(s) in 2006, 10 paper(s) in 2007, 5 paper(s) in 2008, for a total of 20 research publications in total.

Patrice P Viens Author Information

LAST NAME: viens

FIRST NAME: Patrice

INITIALS: p

AFFILIATION:

Papers

Patrice Viens's Publication Record

1. Prognosis and gene expression profiling of 20q13-amplified breast cancers. Year Published: 2006
2. Lung cancer in elderly patients: a retrospective analysis of practice in a single institution. Year Published: 2007
Department of Medicine, Institut Paoli-Calmettes, 232 Bd Sainte Marguerite, 13273 Marseille Cedex 9, France. madroszyka@marseille.fnclcc.fr
3. ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines. Year Published: 2007
4. High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party. Year Published: 2007
Istituto Oncologico Romagnolo-Santa Maria delle Croci Hospital, Ravenna, Italy. ugo_degiorgi@yahoo.com
5. Integrated profiling of basal and luminal breast cancers. Year Published: 2007
6. ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines. Year Published: 2007
7. Prognosis and gene expression profiling of 20q13-amplified breast cancers. Year Published: 2006
8. A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer. Year Published: 2007
9. A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer. Year Published: 2007
10. High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party. Year Published: 2007
Istituto Oncologico Romagnolo-Santa Maria delle Croci Hospital, Ravenna, Italy. ugo_degiorgi@yahoo.com
11. Integrated profiling of basal and luminal breast cancers. Year Published: 2007
12. A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer. Year Published: 2007
13. [Reflections on 4 years of medical practice in the African bush] Year Published: 1974
14. A modified immunofluorescent antibody technique for the serodiagnosis of human toxocaral Larva migrans. Year Published: 1975
15. Epidemiology of Toxocariasis in the Montreal area. Prevalence of Toxocara and other helminth ova in dogs and soil. Year Published: 1977
16. Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. Year Published: 2008
UMR599 Inserm, Institut Paoli-Calmettes, Laboratoire d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Marseille, France.
17. Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis. Year Published: 2008
UMR599 Inserm, Institut Paoli-Calmettes, Laboratoire d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Marseille, France.
18. Defining the molecular biology of inflammatory breast cancer. Year Published: 2008
19. Defining the molecular biology of inflammatory breast cancer. Year Published: 2008
20. Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin. Year Published: 2008